MY164112A - A combination composition comprising ibuprofen and paracetamol - Google Patents

A combination composition comprising ibuprofen and paracetamol

Info

Publication number
MY164112A
MY164112A MYPI2012005317A MYPI2012005317A MY164112A MY 164112 A MY164112 A MY 164112A MY PI2012005317 A MYPI2012005317 A MY PI2012005317A MY PI2012005317 A MYPI2012005317 A MY PI2012005317A MY 164112 A MY164112 A MY 164112A
Authority
MY
Malaysia
Prior art keywords
approximately
paracetamol
ibuprofen
combination composition
combination
Prior art date
Application number
MYPI2012005317A
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of MY164112A publication Critical patent/MY164112A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A COMBINATION COMPOSITION FOR PROVIDING RELIEF FOR PAIN AND/OR INFLAMMATION, THE COMPOSITION HAVING IBUPROFEN AND PARACETAMOL AND BEING SUITABLE FOR USE IN DELIVERING TO A HUMAN INTRAVENOUSLY AT EACH DOSE: A) APPROXIMATELY 375 MG TO APPROXIMATELY 425 MG IBUPROFEN, IN COMBINATION WITH APPROXIMATELY 975 MG TO APPROXIMATELY 1,025 MG PARACETAMOL; OR B) APPROXIMATELY 175 MG TO APPROXIMATELY 225 MG IBUPROFEN, IN COMBINATION WITH APPROXIMATELY 475 MG TO APPROXIMATELY 525 MG PARACETAMOL.
MYPI2012005317A 2010-07-07 2011-06-21 A combination composition comprising ibuprofen and paracetamol MY164112A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ58666110 2010-07-07

Publications (1)

Publication Number Publication Date
MY164112A true MY164112A (en) 2017-11-30

Family

ID=45441395

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012005317A MY164112A (en) 2010-07-07 2011-06-21 A combination composition comprising ibuprofen and paracetamol

Country Status (6)

Country Link
AU (1) AU2011274652B2 (en)
MY (1) MY164112A (en)
NZ (1) NZ604009A (en)
SG (1) SG186388A1 (en)
WO (1) WO2012005605A1 (en)
ZA (1) ZA201208210B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE045442T2 (en) 2010-11-04 2019-12-30 Aft Pharmaceuticals Ltd A combination composition
CN103565733A (en) * 2012-07-31 2014-02-12 南京帝易医药科技有限公司 Ibuprofen sodium chloride injection preparation with pH of 6.0-6.5, and preparation method thereof
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005260243B2 (en) * 2004-07-07 2009-10-29 Aft Pharmaceuticals Limited A combination composition
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method

Also Published As

Publication number Publication date
NZ604009A (en) 2015-03-27
WO2012005605A1 (en) 2012-01-12
AU2011274652B2 (en) 2013-08-15
AU2011274652A1 (en) 2013-01-10
SG186388A1 (en) 2013-01-30
ZA201208210B (en) 2014-04-30

Similar Documents

Publication Publication Date Title
PH12021550804A1 (en) A combination composition
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
MX366090B (en) Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients.
MX2012007933A (en) Topical transdermal dexmedetomidine compositions and methods of use thereof.
EA201290833A1 (en) APPLICATION OF AMISULPRIDE AS ANTI-TRAFFIC MEANS
MX2011011950A (en) Sublingual dexmedetomidine compositions and methods of use thereof.
AR089509A1 (en) METHOD FOR TREATING LOSS OSEA ALVEOLAR, A DENTAL IMPLANT, AN ANTIBODYCEROSTIN ANTIBODY, A GEL OR MATRIX THAT INCLUDES SUCH ANTIBODY AND USE
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
MY164112A (en) A combination composition comprising ibuprofen and paracetamol
GB2476418A (en) A medicinal product and treatment
WO2009012472A3 (en) Methods and compositions for treating conditions
MX2013010947A (en) Gallium complexes, pharmaceutical compositions and methods of use.
MX2009008813A (en) Pharmaceutical composition containing phloroglucinol and paracetamol.
BR112015011408A2 (en) dispersible tablet
CL2012003065A1 (en) Pharmaceutical combination comprising ibuprofen and l-arginine in a weight ratio of ibuprofen / l-arginine between 1.6 and 5.6, with the exception of the value 1.97; solid pharmaceutical composition containing said combination; and its use in the treatment of pain, inflammation and / or fever.
WO2008091957A3 (en) Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity
MX2015013911A (en) Synergistic combination of paracetamol/celecoxib for the treatment of inflammatory pain.
HK1135030A1 (en) Composition useful for the treatment of type 2 diabetes
HRPK20070344B3 (en) Yoghurt with propolis and pollen
SA515360445B1 (en) Dispersible tablet
UA29192U (en) Adsorbing preparation with combined therapeutic action
UA101837C2 (en) Injection agent with immunostimulant and systemic properties based on honey
MY154883A (en) A combination composition
UA54168U (en) Method for preventing recurrences in patients with localized sclerodermia
RU2012158011A (en) METHOD AND COMPOSITION FOR TREATMENT OF CANCER